ArcelorMittal SA Value Stock - Dividend - Research Selection
Market price: 30,14 USD
ArcelorMittal SA Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||4.082.000.000|
|Free cash flow||1.643.000.064|
|Liabilities & Shareholders equity||82.052.000.000|
|Diluted shares outstanding||1.140.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||34.827.001.856,00 USD|
|Indices||AEX 25,CAC 40,IBEX 35,STOXX EUROPE 600,MSCI World Index|
|Raw Data Source||IFRS in Millionen USD|
|Stock Split||2017-05-23,1.0000/3.0000; 2017-05-22,1.0000/3.0000; 2016-03-14,1275.000000/1013.000000; 2014-10-02,1.0000/14.0000|
Description of the company
ArcelorMittal SA is a Luxembourg-based company involved in the mining and steel industry. It operates in divisions: Flat Carbon Americas; Flat Carbon Europe, Long Carbon Americas and Europe; Asia, Africa and Commonwealth of Independent States (CIS) (AACIS), and Distribution Solutions. The Company's portfolio of products includes finished, semi-finished, long and flat products, such as slabs, hot-rolled coil, cold-rolled coil, coated steel products, tinplate and heavy plate, as well as billets, blooms, rebars, wire rod, sections, rails, sheet piles and drawn wire. Its products are sold to the steel-consuming industries including automotive, heavy machinery, pipes and tubes, construction, packaging and appliances. It operates through numerous subsidiaries in the United States, Canada, Brazil, France, Germany, Kazakhstan, Ukraine, South Africa, among others. In November 2013, it divested its subsidiary Etilam.